You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Herantis Pharma as an Investment | Life Science Night Dec 9, 2025

By Inderes

Antti Vuolanto, CEO, talks about biotechnology company Herantis Pharma as an investment.


Life Science Night 2025

  • Keynote – Antti Siltanen, Inderes (link)
  • Orion Pharma – Tuukka Hirvonen, Head of Investor Relations (link)
  • Aiforia – Jukka Tapaninen, CEO (link)
  • Herantis Pharma – Antti Vuolanto, CEO (link)


Life Science Night December 9, 2025 (link)
Life Science Night December 2, 2024 (link)